Thomas Walle is a physician specializing in Medical Oncology at the National Center for Tumor Diseases (NCT) Heidelberg since March 2018. Concurrently, Thomas has served as a scientist and doctoral student at the DKFZ German Cancer Research Center since 2014. Thomas gained additional research experience as a research fellow in Dr. Dana Pe‘er’s laboratory at Memorial Sloan Kettering Cancer Center from April 2022 to April 2023, focusing on immune cell states in human tumors. Thomas's educational background includes degrees from various institutions, including Heidelberg University, where studies were pursued from 2012 to 2017, and additional experiences at The University of Texas Health Science Center at Houston, Imperial College London, University of Navarra, University of Sydney, and Kiel University.
National Center for Tumor Diseases (NCT) Heidelberg
The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), Heidelberg University Hospital and German Cancer Aid. The NCT's goal is to link promising approaches from cancer research with patient care from diagnosis to treatment, aftercare and prevention. The interdisciplinary tumor outpatient clinic is the central element of the NCT. Here the patients benefit from an individual treatment plan prepared in a timely manner in interdisciplinary expert rounds, the so-called tumor boards. Participation in clinical studies provides access to innovative therapies. The NCT thereby acts as a pioneering platform that translates novel research results from the laboratory into clinical practice. The NCT cooperates with self-help groups and supports them in their work. Since 2015, a second site for the NCT beside Heidelberg has been under development in Dresden.